The effect of Glucagon-Like Peptide-2 on mesenteric blood flow and cardiac parameters in end-jejunostomy short bowel patients

Research output: Contribution to journalJournal articleResearchpeer-review

Exogenous Glucagon-Like Peptide-2 (GLP-2) treatment improves intestinal wet weight absorption in short bowel syndrome (SBS) patients. In healthy subjects, administration of GLP-2 increases small intestinal blood flow. The aim of the study was to evaluate the effect of GLP-2 on mesenteric blood flow and dynamic changes in cardiac parameters in SBS patients with jejunostomy and varying length of remnant small intestine.
Original languageEnglish
JournalRegulatory Peptides
Issue number1-3
Pages (from-to)32-8
Number of pages7
Publication statusPublished - 2011

    Research areas

  • Adult, Aged, Blood Pressure, Cardiac Output, Female, Glucagon-Like Peptide 2, Heart Rate, Humans, Male, Mesenteric Arteries, Middle Aged, Regional Blood Flow, Short Bowel Syndrome, Young Adult

ID: 34043197